Ainos Inc

Ainos, Inc. is a dual-platform company focused on artificial intelligence-based smell technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system that uses a smell language model to digitize scent into Smell IDs and machine-readable data. Its platforms serve semiconductor manufacturing, robotics, smart manufacturing, senior care, and women's health. The company also develops VELDONA, a low-dose oral interferon platform for human and animal health applications targeting rare, autoimmune, and infectious diseases. Formerly known as Amarillo Biosciences, Inc., it changed its name to Ainos, Inc. in May 2021. Incorporated in 1984 and based in Houston, Texas, it is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Semiconductors▲

Ainos Shares Rise 6.9% on Initial AI Nose Semiconductor Orders

Ainos Inc. shares rose 6.9% in pre-market trading on Monday after the company said it received initial commercial orders for its AI Nose platform from a front-end semiconductor manufacturer. The orders follow technical validation activities involving approximately 200 AI Nose systems deployed at wafer fabrication facilities since March, and Ainos said they represent a move from validation to commercial deployment in semiconductor manufacturing environments. Financial terms and the identity of the customer were not disclosed. The company said the initial commercial orders are expected to provide revenue opportunities beginning in the second half of 2026, and it is deploying the technology in both front-end wafer fabrication and back-end semiconductor packaging and testing operations. Separately, Ainos said its proprietary real-world chemical dataset has exceeded one billion records, compared with approximately 878 million reported in August.

AIMD ▲

Semiconductors

Yahoo Finance·4dRead more →